Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Fox

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Pathology|October 13, 2023
Real-world prevalence of PD-L1 expression in non-small cell lung cancer: an Australia-wide multi-centre retrospective observational studyPrudence A Russell, Alexandra L Farrall, Sarita Prabhakaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2009
Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomasDariush Etemadmoghadam, Anna deFazio, Rameen Beroukhim, et al.
Breast Cancer Research : BCR|February 2, 2011
Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family RegistryLetitia D Smith, Andrea A Tesoriero, Ee M Wong, et al.
Breast Cancer Research and Treatment|December 5, 2009
Subtypes of familial breast tumours revealed by expression and copy number profilingNic Waddell, Jeremy Arnold, Sibylle Cocciardi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 7, 2024
Revisiting surgical margins for invasive breast cancer patients treated with breast conservation therapy - Evidence for adopting a 1 mm negative widthEmad A Rakha, Cecily Quinn, Yazan A Masannat, et al.
British Journal of Cancer|September 17, 2020
Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1Emarene Kalaw, Malcolm Lim, Jamie R Kutasovic, et al.
Cancers|September 9, 2023
A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature ReviewArwa Abdelmogod, Lia Papadopoulos, Stephen Riordan, et al.
Breast Cancer Research : BCR|July 8, 2010
HER3 and downstream pathways are involved in colonization of brain metastases from breast cancerLeonard Da Silva, Peter T Simpson, Chanel E Smart, et al.
The Journal of Pathology|February 1, 2024
Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinomaBraydon Meyer, Clare Stirzaker, Sonny Ramkomuth, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013)Vito Amoroso, Daniele Generali, Thomas Buchholz, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Pathology|October 13, 2023
Real-world prevalence of PD-L1 expression in non-small cell lung cancer: an Australia-wide multi-centre retrospective observational studyPrudence A Russell, Alexandra L Farrall, Sarita Prabhakaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2009
Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomasDariush Etemadmoghadam, Anna deFazio, Rameen Beroukhim, et al.
Breast Cancer Research : BCR|February 2, 2011
Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family RegistryLetitia D Smith, Andrea A Tesoriero, Ee M Wong, et al.
Breast Cancer Research and Treatment|December 5, 2009
Subtypes of familial breast tumours revealed by expression and copy number profilingNic Waddell, Jeremy Arnold, Sibylle Cocciardi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 7, 2024
Revisiting surgical margins for invasive breast cancer patients treated with breast conservation therapy - Evidence for adopting a 1 mm negative widthEmad A Rakha, Cecily Quinn, Yazan A Masannat, et al.
British Journal of Cancer|September 17, 2020
Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1Emarene Kalaw, Malcolm Lim, Jamie R Kutasovic, et al.
Cancers|September 9, 2023
A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature ReviewArwa Abdelmogod, Lia Papadopoulos, Stephen Riordan, et al.
Breast Cancer Research : BCR|July 8, 2010
HER3 and downstream pathways are involved in colonization of brain metastases from breast cancerLeonard Da Silva, Peter T Simpson, Chanel E Smart, et al.
The Journal of Pathology|February 1, 2024
Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinomaBraydon Meyer, Clare Stirzaker, Sonny Ramkomuth, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013)Vito Amoroso, Daniele Generali, Thomas Buchholz, et al.
Pageof 12